Эмитент	Доля, %	P/BV	P/S	P/E	EV/Ebitda
Amyris, Inc.	3.22		24.24		-40.64
Rubius Therapeutics, Inc.	1.72	12.95			-11.69
Five Prime Therapeutics, Inc.	1.46	6.56	134.08		-20.45
Cara Therapeutics	1.28	5.51	10.15	155.31	228.86
Prothena Corporation plc	1.16	5.07	1.205		-5.7
Orchard Therapeutics plc	0.97	3.67	312.69		-4.76
ImmunityBio, Inc.	0.93		2.344		-58.61
Novavax, Inc.	0.91	19.73	27.08		-31.71
Vir Biotechnology, Inc.	0.89	6.16	73.29		-18.43